Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom
| Year of publication: |
2011
|
|---|---|
| Authors: | Botteman, M. ; Meijboom, M. ; Foley, I. ; Stephens, J. ; Chen, Y. ; Kaura, S. |
| Published in: |
The European Journal of Health Economics. - Springer. - Vol. 12.2011, 6, p. 575-588
|
| Publisher: |
Springer |
| Subject: | Renal cell carcinoma | Bone health | Cost-effectiveness | Bone metastases | Bisphosphonates | I19 - Other |
| Extent: | text/html |
|---|---|
| Type of publication: | Article |
| Source: |
Persistent link: https://www.econbiz.de/10010845740